143 related articles for article (PubMed ID: 10761804)
1. Electropharmacologic effect of a standard dose of intravenous procainamide in patients with sustained ventricular tachycardia.
Rials SJ; Britchkow D; Marinchak RA; Kowey PR
Clin Cardiol; 2000 Mar; 23(3):171-4. PubMed ID: 10761804
[TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
[TBL] [Abstract][Full Text] [Related]
3. The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide.
Gold RL; Frumin H; Haffajee CI; Kerin NZ; Jarandilla R
Pacing Clin Electrophysiol; 1988 Mar; 11(3):308-14. PubMed ID: 2452418
[TBL] [Abstract][Full Text] [Related]
4. Effects of incremental doses of procainamide in patients with sustained uniform ventricular tachycardia.
Grimm W; Cho JG; Marchlinski FE
J Cardiovasc Electrophysiol; 1994 Apr; 5(4):313-22. PubMed ID: 8019707
[TBL] [Abstract][Full Text] [Related]
5. Procainamide induced change of the width of the zone of entrainment and its relation to the inducibility of reentrant ventricular tachycardia.
Aizawa Y; Tanabe Y; Naitoh N; Washizuka T; Shibata A; Josephson ME
Pacing Clin Electrophysiol; 1997 Nov; 20(11):2789-98. PubMed ID: 9392810
[TBL] [Abstract][Full Text] [Related]
6. Procainamide-induced changes in reentrant ventricular tachycardia with special reference to the tachycardia-interrupting critical paced cycle length during transient entrainment with rapid pacing.
Aizawa Y; Naitoh N; Washizuka T; Kitazawa H; Takahashi K; Kodama I; Shibata A
Jpn Heart J; 1994 Sep; 35(5):611-23. PubMed ID: 7830326
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiologic properties and antiarrhythmic mechanisms of intravenous N-acetylprocainamide in patients with ventricular dysrhythmias.
Sung RJ; Juma Z; Saksena S
Am Heart J; 1983 May; 105(5):811-9. PubMed ID: 6189384
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiologic and clinical factors influencing response to class IA antiarrhythmic agents in patients with inducible sustained monomorphic ventricular tachycardia.
Gold RL; Haffajee CI; Alpert JS
Am Heart J; 1986 Jul; 112(1):9-13. PubMed ID: 3728294
[TBL] [Abstract][Full Text] [Related]
9. Effects of incremental doses of procainamide on ventricular refractoriness, intraventricular conduction, and induction of ventricular tachycardia.
Morady F; DiCarlo LA; de Buitleir M; Krol RB; Baerman JM; Kou WH
Circulation; 1986 Dec; 74(6):1355-64. PubMed ID: 2430731
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
[TBL] [Abstract][Full Text] [Related]
11. Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction.
Kus T; Costi P; Dubuc M; Shenasa M
Am Heart J; 1990 Oct; 120(4):855-63. PubMed ID: 2220538
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiologic mechanisms of antiarrhythmic efficacy of a sotalol and class Ia drug combination: elimination of reverse use dependence.
Lee SD; Newman D; Ham M; Dorian P
J Am Coll Cardiol; 1997 Jan; 29(1):100-5. PubMed ID: 8996301
[TBL] [Abstract][Full Text] [Related]
13. Prospective comparison of intravenous quinidine and intravenous procainamide in patients undergoing electrophysiologic testing.
Holzberger PT; Greenberg ML; Paicopolis MC; Ozahowski TP; Ho PC; O'Connor GT
Am Heart J; 1998 Jul; 136(1):49-56. PubMed ID: 9665218
[TBL] [Abstract][Full Text] [Related]
14. Prediction of antiarrhythmic efficacy of class I and III agents in patients with ventricular tachycardia by signal-averaged ECG analysis.
Kulakowski P; Bashir Y; Heald S; Paul V; Anderson MH; Gibson S; Malik M; Camm AJ
Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2116-21. PubMed ID: 1279610
[TBL] [Abstract][Full Text] [Related]
15. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease.
Wynn J; Miura DS; Torres V; Flowers D; Keefe D; Williams S; Somberg JC
Am J Cardiol; 1985 Nov; 56(13):877-81. PubMed ID: 2414983
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug.
Aizawa Y; Chinushi M; Naitoh N; Shibata A
Heart; 1996 Feb; 75(2):165-70. PubMed ID: 8673755
[TBL] [Abstract][Full Text] [Related]
18. Electropharmacologic testing in sustained ventricular tachycardia associated with coronary heart disease: value of the response to intravenous procainamide in predicting the response to oral procainamide and oral quinidine treatment.
Oseran DS; Gang ES; Rosenthal ME; Mandel WJ; Peter T
Am J Cardiol; 1985 Nov; 56(13):883-6. PubMed ID: 3904387
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of an open-loop, computer-based infusion system designed to achieve a series of constant, targeted plasma procainamide concentrations in patients undergoing electrophysiologic testing.
Coyle JD; Carnes CA; Schaal SF
Pharmacotherapy; 1997; 17(3):445-56. PubMed ID: 9165549
[TBL] [Abstract][Full Text] [Related]
20. Use-dependent prolongation of ventricular tachycardia cycle length by type I antiarrhythmic drugs in humans.
Kidwell GA; Greenspon AJ; Greenberg RM; Volosin KJ
Circulation; 1993 Jan; 87(1):118-25. PubMed ID: 8418998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
